Antithrombotic Therapy for VTE Disease Clive Kearon, MD, PhD, Elie A. Akl, MD, MPH, PhD, Anthony J. Comerota, MD, Paolo Prandoni, MD, PhD, Henri Bounameaux, MD, Samuel Z. Goldhaber, MD, FCCP, Michael E. Nelson, MD, FCCP, Philip S. Wells, MD, Michael K. Gould, MD, FCCP, Francesco Dentali, MD, Mark Crowther, MD, Susan R. Kahn, MD  CHEST  Volume 141, Issue 2, Pages e419S-e496S (February 2012) DOI: 10.1378/chest.11-2301 Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 1 Phases of anticoagulation. LMWH = low-molecular-weight heparin. CHEST 2012 141, e419S-e496SDOI: (10.1378/chest.11-2301) Copyright © 2012 The American College of Chest Physicians Terms and Conditions